Litcius/Paper detail

Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre study

Victoria Furer, Tali Eviatar, Tal Freund, Hagit Peleg, Daphna Paran, David Levartovsky, Ilana Kaufman, Adi Broyde, Ofir Elalouf, Ari Polachek, Joy Feld, Amir Haddad, Tal Gazitt, Muna Elias, Nizar Higazi, Fadi Kharouf, Smadar Gertel, Sara Pel, Sharon Nevo, David Hagin, Devy Zisman, Ori Elkayam

2022Annals of the Rheumatic Diseases38 citationsDOI

Topics & Concepts

MedicineImmunogenicityImmunologyBiosimilarInternal medicineAntibodySARS-CoV-2 and COVID-19 ResearchRheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus Research
Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre study | Litcius